Paul S. Changelian
Washington University in St. Louis(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Immune Cell Function and Interaction, Pharmacological Effects of Natural Compounds, T-cell and B-cell Immunology, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor(1996)1,951 cited
- → Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor(2003)668 cited
- → Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection(2010)332 cited
- → A new modality for immunosuppression: targeting the JAK/STAT pathway(2004)298 cited
- → PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models(2013)254 cited
- → Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease(2012)231 cited
- →